BackFinch Therapeutics Group Overview

Finch Therapeutics Group Cost of Revenue

Cost of Revenue analysis for FNCH.

Quarterly Cost of Revenue

N/A

As of Jun 30, 2024

Annual Cost of Revenue (TTM)

$139000.00
90.24% YoY

Trailing 12 months ending Jun 30, 2024

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)